Voisin Consulting Life Sciences presentation icon
Presentation

Understanding the Implications of the New IVDR for Companion Diagnostics (CDx)

Post thumbnail Understanding the Implications of the New IVDR for Companion Diagnostics (CDx)

IVD Regulation is evolving, with direct impacts on CDx development. The purpose of this presentation will be to explore special provisions for CDx in the new IVDR, outline when industry need to start implementing these special provisions, determine how Notified Bodies are dealing with the new IVDR and impact on CDx, discuss what the role of the EMA will be for CDx, and review what the new IVDR will mean for CDx labelling and laboratory developed tests.

Voisin Consulting Life Sciences download icon

Download the full presentation now

Fill in the form to download the content

    Yes, I would like to receive communications regarding VCLS services and events

    Sample of the presentation

    presentation by

    Voisin Consulting Life Sciences default post thumbnail
    Sylvie Le Glédic, PhD
    Director, Medical Devices & IVD